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Abstract
Testing for genetic effects on mean values of a quantitative trait has been a very successful strategy. However, most studies
to date have not explored genetic effects on the variance of quantitative traits as a relevant consequence of genetic
variation. In this report, we demonstrate that, under plausible scenarios of genetic interaction, the variance of a quantitative
trait is expected to differ among the three possible genotypes of a biallelic SNP. Leveraging this observation with Levene’s
test of equality of variance, we propose a novel method to prioritize SNPs for subsequent gene–gene and gene–
environment testing. This method has the advantageous characteristic that the interacting covariate need not be known or
measured for a SNP to be prioritized. Using simulations, we show that this method has increased power over exhaustive
search under certain conditions. We further investigate the utility of variance per genotype by examining data from the
Women’s Genome Health Study. Using this dataset, we identify new interactions between the LEPR SNP rs12753193 and
body mass index in the prediction of C-reactive protein levels, between the ICAM1 SNP rs1799969 and smoking in the
prediction of soluble ICAM-1 levels, and between the PNPLA3 SNP rs738409 and body mass index in the prediction of
soluble ICAM-1 levels. These results demonstrate the utility of our approach and provide novel genetic insight into the
relationship among obesity, smoking, and inflammation.
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Introduction
Most genetic association studies have so far emphasized the
effect of SNPs on mean values of a trait of interest. While this
approach has been widely successful in identifying genetic
determinants of quantitative traits, it does not make use of
differences in the variance of these traits per genotype, which may
reflect an alternative mode of genetic influence and signify
biological relevance. Several scenarios can result in the variance
of a quantitative trait being different when individuals are stratified
by SNP genotype (or any other genetic variation) in cross-sectional
designs. For examples, such difference could be ascribed to
increased variation over time among individuals of a given
genotype, increased variation in the homeostatic set-point of a trait
(without increased variation over time), or an interaction effect
with another SNP or exposure. This latter possibility is particularly
attractive since information on variance per genotype could thus
be leveraged to reduce the dimensionality of interaction analysis
by prioritizing SNPs for further interaction testing.
Several methods have been developed to address the statistical
challenge of assessing the degree and nature of interaction between
two or more genetic loci [1–4]. While these offer invaluable
insight, most do not address the main problem pertaining to
interaction testing in the context of whole genome association
studies: the multiple hypothesis testing incurred when searching
for interactions between hundreds of thousands of genetic variants.
In theory, excluding unlikely interactions on an a priori basis will
result in a lower number of false positives tests and increased
power. Current data reduction methods use evidence of co-
adaptation between loci to restrict the search space [5] or specify a
minimum marginal effect to select a subset of SNPs for interaction
testing [6–8]. This latter method is based on the assumption that
interacting SNPs will show at least a moderate effect on the trait of
interest. While this premise might be valid in most cases, it need
not be, as has been observed [2,9,10]. Furthermore, even when
restricting the search for interaction to SNPs with marginal effect
P-values lower than 0.1, as has been suggested [7], a sizeable
number of hypotheses will have to be tested. Thus there is a need
for novel methods to identify SNPs likely to be involved in gene-
gene and gene-environment interactions. Murcray et al. [11]
recently proposed a two-step approach to test for gene-environ-
ment interactions in genome-wide association studies. In the
context of dichotomous outcomes, this method first tests for gene-
environment association, followed by conventional interaction
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combined case-control sample.
In this report, we first derive expressions for the variance
according to SNP genotype under models of genetic interactions
and demonstrate that the variance of a quantitative trait will differ
between the three possible genotypes of a biallelic SNP in the
presence of genetic interactions. Building on these derivations, we
then simulate data to explore contexts where testing for inequality
of variance between genotypes could be used to prioritize SNPs for
further interaction testing. Leveraging these observations, we
propose a novel method to prioritize SNPs for gene-gene and
gene-environment interaction, ‘‘variance prioritization’’. Variance
prioritization entails two steps. In the first step, Levene’s test of
equality of variance is used to prioritize SNPs for further
interaction testing. In the second step, prioritized SNPs are tested
for interaction effects against environmental covariates or other
SNPs using linear regression. We use data from the Women’s
Genome Health Study (WGHS) on two inflammation markers, C-
reactive protein and soluble ICAM-1, to test whether (1) there is
empirical confirmation of SNPs demonstrating inequality of
variance between genotypes and (2) whether such SNPs show
evidence of either gene-environment or gene-gene interactions.
Methods
Ethics statement
All analyses were performed with approval of the institutional
review board of the Brigham and Women’s Hospital. All members of
the WGHS cohort were participants in the WHS who provided an
adequate baseline blood sample for plasma and DNA analysis and
who gave consent for blood-based analyses and long-term follow-up.
Variance of a quantitative trait by genotype in the
presence of an interaction effect
Consider a biallelic SNP G with minor allele frequency p and in
Hardy-Weinberg equilibrium. Without loss of generality and
assuming an additive genetic effect of G on a quantitative trait of
interest, G can be encoded as -2p, 1-2p, or 2-2p such that mean
genotype equals zero. Assume that there is an additive interaction
between G and a covariate C (with mean equal to zero, variance
equal to one, and uncorrelated to G) such that the quantitative
trait Y for the ith individual is represented as:
yi~b0zb1gizb2cizb3gicizei ð1Þ
Where b0, b1, b2, and b3 represent constants for the intercept, the
marginal effect of G, the marginal effect of C, and the interaction
of G and C, respectively. It is assumed the outcome is standardized
so it has unit variance conditional on G and C, that is, the error
term ei,N(0,1). The variance in Y conditional on genotype of G
can be written as:
Var(YDG~g)~Var(b0zb1gzb2Czb3gCze)
~0z0z Var(b2C)z Var(b3gC)z2Cov(b2C,b3gC)z1
~b
2
2zb
2
3g2z2b2b3gz1
~(b2zb3g)
2z1
ð2Þ
Where coefficients represent true rather than estimated effects.
Thus, the variance of Y will differ by genotype group (g) when
b3?0. Importantly, the variance does not depend on the marginal
effect of G on Y (i.e. b1). Furthermore, as we did not specify the
distribution form of the interacting covariate C, Equation 3 can be
generalized to different types of interaction such as dichotomous
environmental exposures, continuous environmental exposures or
the three genotype classes of a biallelic SNP. The total variance of
Y is given by:
Var(Y)~Var(b1Gzb2Czb3GCze)
~Var(b1G)zVar(b2C)zVar(b3GC)z1
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Where the three covariance terms are zero because of the assum-
ption of G and C independence. It results from equation (3) that
the proportion of total variance attributable to the marginal effect
of the covariate (i.e. b2) can be defined as:
b
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Similarly, the proportion of total variance attributable to the SNP-
covariate interaction (i.e. b3) can be defined as:
2b
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3p(1{p)
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2
1zb
2
2z2p(1{p)b
2
3z1
ð5Þ
Levene’s test for equality of variance
Levene’s test [12] is used to test if k samples have equal
variances and is less sensitive to deviation from normality than the
Author Summary
Finding gene–gene and gene–environment interactions is
a major challenge in genetics. In this report, we propose a
novel method to help detect these interactions. This
method works by first identifying a subset of genetic
variants more likely to be involved in genetic interactions
and then testing these variants for interaction effects.
Using this method, we were able to identify three
previously unknown genetic interactions. The first interac-
tion involves a measure of body fat and a genetic variant
of the LEPR gene in the prediction of C-reactive protein
concentration, a marker of inflammation. The second
interaction involves the same measure of body fat and a
genetic variant of the PNPLA3 gene in the prediction of
ICAM-1 levels, also a marker of inflammation. These results
are significant because both LEPR and PNPLA3 are linked to
the biological response to increased body fat, and
inflammation itself is known to be increased in obesity
and is thought to contribute to its adverse health effect.
Finally, a third interaction was identified between a genetic
variant of the ICAM1 gene and smoking in the prediction
of ICAM-1 levels. The ICAM1 gene encodes ICAM-1 itself
and smoking is known to be an important determinant of
ICAM-1 concentrations.
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empirical data led to marked inflation of type I error and was not
pursued further (data not shown). The Levene test assesses the null
hypothesis that the population variances are equal:
H0: s1~s2~:::~sk
Ha: si=sj for at least one pair (i,j).
Given a variable Y with sample of size N divided into k subgroups,
where Ni is the sample size of the ith subgroup, the Levene test
statistic is defined as:
W~
(N{k)
Pk
i~1 Ni( Z Zi:{ Z Z::)
2
(k{1)
Pk
i~1
PNi
j~1 (Zij{ Z Zi:)
2
WhereZij~DYij{ Y Yi:D withYij the valueofYforthe jthobservation
of the ith subgroup,  Y Yi: the mean of the ith subgroup,  Z Zi: are the
group means of the Zij and  Z Z:: is the overall mean of the Zij.
The Levene test rejects the hypothesis that the variances are
equal if:
WwF(a,k{1,N{k)
Where F(a,k{1,N{k) is the upper critical value of the F distribution
with k21 and N2k degrees of freedom at a significance level of a.
Simulations of interaction effects
We used simulations to estimate the power of Levene’s test to
detect differences in variance of a quantitative trait between
individuals of differing genotypes. We first simulated the case of a
SNP (denoted SNP1) interacting with a covariate (denoted C1)i n
determining the value of a quantitative trait (denoted Y; see
Figure 1). We assumed the main effect of SNP1 to be null in all
simulations because it is expected to affect neither the within
genotype variance (see Equation 2) nor the power to detect the
interaction. For simplicity, only results from the additive genetic
model (assuming an additive contribution of each minor allele; see
Equation 1) are shown but similar conclusions can be derived from
more general models of association. Under a range of models for
the main effect of C1 (on the quantitative trait), allelic frequency of
SNP1, and interaction between SNP1 and C1, we tested the power
of Levene’s test to reject the null hypothesis that the variance of Y
does not vary between subsets of individuals with differing
genotypes (of SNP1). In all simulations, the quantitative trait was
assumed to have a normally distributed error term with mean
equal to zero and variance equal to 1. The covariate was normally
distributed with mean equal to zero and variance equal to 1.
Interactions are expected to be modest at best and simulations
were therefore restricted to interaction effects explaining up to 1%
of the quantitative trait’s total variance. Each condition was
simulated 1,000 times using 15,000 individuals unless otherwise
specified. In a second set of simulations, we tested the power of
Levene’s test of equality of variance to detect SNP-SNP
interactions. These simulations are based on a model similar to
the one previously introduced, with the exception that the
normally distributed covariate (C1) is replaced by a second,
independent, SNP (denoted SNP2). To simplify simulations, both
SNPs were assigned the same allelic frequency as well as the same
main effect (i.e. SNP-Y association). Varying the strength of the
SNP1- SNP2 interaction, we simulated each condition 1,000 times
using 15,000 individuals unless otherwise specified.
Variance prioritization
Leveraging two observations that (1) the signature of a SNP-
covariate interaction may be inequality of variance between SNP
Figure 1. Model of interaction.
doi:10.1371/journal.pgen.1000981.g001
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a subsequent direct test of interaction, we propose a novel method
to prioritize SNPs for gene-gene and gene-environment interac-
tion, termed ‘‘variance prioritization’’. This prioritization proce-
dure first applies Levene’s test of variance equality to selects SNPs
below a pre-specified threshold and then tests these ‘‘prioritized’’
SNPs for gene-environment or gene-gene interaction using
standard linear regression models (see Figure 2), with Bonferroni
correction only for the number statistical tests prioritized in the
first step. Using simulation models, we explored the power of
variance prioritization and compared it to an exhaustive search for
interaction, without prior prioritization, followed by Bonferroni
correction for multiple hypothesis testing.
Independence of variance per genotype from estimates of
interaction effects under the null of no interaction is important
because the validity of the method rests on having correct type I
error. A proof of independence between variance per genotype
and estimation of interaction effect under the null of no interaction
is presented in Text S1 and Figure S1.
WGHS participants
The study population was derived from the Women’s Genome
Health Study (WGHS) [14]. Briefly, participants in the WGHS
include American women from the Women’s Health Study (WHS)
with no prior history of cardiovascular disease, cancer, or other
major chronic illness who also provided a baseline blood sample at
the time of study enrollment from which genomic DNA was
extracted [15]. Individuals with self-reported diabetes at enroll-
ment (or with glycated hemoglobin .7%) or taking lipid lowering
medication were excluded from analysis.
All baseline blood samples underwent measurement for high-
sensitivity CRP (hsCRP) via a validated immunoturbidometric
method (Denka Seiken, Tokyo, Japan). CRP is an inflammatory
biomarker with strong prognostic value for development of
metabolic syndrome, diabetes, myocardial infarction, and stroke.
Log-transformed CRP levels were used in all analyses. Soluble
ICAM-1 is an inflammatory marker that has been associated with
several common diseases such as diabetes, heart disease, stroke
and malaria. Circulating plasma sICAM-1 concentrations were
determined using a commercial ELISA assay (R&D Systems,
Minneapolis, Minn.) The environmental factors tested for
interaction included self-reported body mass index, menopause
status, hormone replacement therapy use, smoking, age and
exercise, expressed as quintiles of total energy expenditure spent
from all recreational activities.
Genotyping
DNA samples were genotyped with the Infinium II technology
from Illumina. Either the HumanHap300 Duo-Plus chip or the
combination of the HumanHap300 Duo and I-Select chips were
used. In either case, the custom content was identical and
consisted of candidate SNPs chosen without regard to allele
frequency to increase coverage of genetic variation with impact on
biological function including metabolism, inflammation or cardio-
vascular diseases. Genotyping at 318,237 HumanHap300 Duo
SNPs and 45,571 custom content SNPs was attempted, for a total
of 363,808 SNPs. Genetic context for all annotations are derived
from human genome build 36.1 and dbSNP build 126.
SNPs with call rates ,90% were excluded from further analysis.
Likewise, all samples with percentage of missing genotypes higher
than 2% were removed. Among retained samples, SNPs were further
evaluated for deviation from Hardy-Weinberg equilibrium using an
exact method and were excluded when the P-value was lower than
10
26. SNPs with minor allele frequency .1% in Caucasians were
used for analysis. 339,596 SNPs were left after quality control. All
statistical analyses were done with R, unless specified otherwise. All
analyses were performed on individuals of self-reported Caucasian
ancestry, with confirmation using a principal component analysis. A
total of 21,799 individuals were included in our final dataset.
Results
Building on the theoretical observation that the within genotype
variance of a quantitative trait will vary when a genetic interaction
Figure 2. The variance prioritization procedure.
doi:10.1371/journal.pgen.1000981.g002
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variance to detect interactions. We first tested the power of
Levene’s test to detect a SNP (denoted SNP1) interacting with a
single covariate, C1 (see Figure 1). As shown in Figure 3, the power
of Levene’s test to identify a SNP as interacting with a covariate
was modest in most situations. For example, when the interaction
effect explained 0.4% of the variance of a quantitative trait, the
allelic frequency was 0.2 and the covariate was associated with the
quantitative trait with b2=0.3 (explaining 8.2% of the variance;
see Figure 3B), the power of Levene’s test to identify a SNP as
‘‘interacting’’ at P,0.05 was 82.5% whereas the power of linear
regression to identify the interaction at P,1.5610
27 was 99.6%.
In other words, even after accounting for 340,000 tests using
Bonferroni correction, testing for gene-environment interactions
with linear regression was more powerful than testing for
inequality of variance between genotypes at nominal significance.
Nevertheless, as can be observed in Figure 3, there were
situations involving small interaction effects explaining less than
0.4% of the variance for which a nominally significant Levene’s
test was more powerful than linear regression testing (after
multiple hypothesis correction). Because SNP effects on variance
per genotype is independent of the estimates of interaction effects,
variance prioritization could provide a method for decreasing the
multiple testing burden in these situations, with ensuing increased
power. To test the power of variance prioritization for small
interaction effects, we performed further simulations in which we
varied Levene’s test P-value threshold used to prioritize SNPs for
interaction testing (see Figure 4). For these simulations, we used
Figure 3. Power to detect a SNP–covariate interaction effect as function of the proportion of variance explained by the interaction.
Each condition was simulated 1,000 times with 15,000 individuals according to the model shown in Figure 1. MAF refers to the minor allele frequency
of SNP1 and b2 refers to the b coefficient of the C1-Y association. In all cases, SNP1 had no marginal effect (i.e. b1=0). Upper panel: Power to identify
SNP1 as an ‘‘interacting’’ SNP using Levene’s test with a P-value threshold of 0.05 (black), 0.01 (red) and 1.5610
27 (green; to account for 340,000 tests
using Bonferroni correction). Also shown is the power to detect the interaction itself with a linear regression interaction P-value cut-off of 1.5610
27
(blue). Lower panel: The variance per genotype is illustrated as a function of the fraction of the total variance of the quantitative trait explained by the
interaction. The homozygous major allele genotype is drawn in black, the heterozygous genotype in red and the homozygous minor allele genotype
in green.
doi:10.1371/journal.pgen.1000981.g003
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PLoS Genetics | www.plosgenetics.org 5 June 2010 | Volume 6 | Issue 6 | e1000981Figure 4. Power of variance prioritization as function of the Levene’s test P-value prioritization threshold. Each condition was
simulated 2,000 times with 15,000 individuals. For each condition, the Levene’s test P-value threshold was varied from 0 to 1 and the power of
variance prioritization calculated after accounting for multiple testing (assuming 340,000 SNPs were initially tested), as illustrated by black lines. SNP-
covariate interactions were simulated in (A–D). In the case of SNP-covariate interactions, all prioritized SNPs were tested for interaction with the
covariate. Red lines represent the power to detect the interaction with linear regression when correcting for all 340,000 tested SNPs (P,1.5610
27). In
Using Variance per Genotype to Detect Interactions
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Figure 3D (Figure 4C and 4D), fixing b 3 such that the interaction
explained 0.1% or 0.15% of total variance. We subsequently
interrogated the prioritized SNPs for interaction effects using
linear regression and applied a Bonferroni correction assuming
340,000 SNPs were initially tested (ex.: if Levene’s test P-value cut-
off is 0.01 then upon further interaction testing a SNP will be
deemed significant if its interaction P-value is ,0.05/
(0.016340,000)). We then compared the results of variance
prioritization with a ‘‘conventional’’ method correcting for
340,000 tests. Each condition was simulated 2,000 times. As
illustrated in Figure 4A–4D, variance prioritization was more
powerful than conventional methods to detect gene-environment
interactions, with the increase in power dependent on the Levene’s
test P-value threshold used. In almost all cases, the power was at
least equal to performing an exhaustive search for gene-
environment interactions with all 340,000 SNPs.
Similar simulations were performed for SNP-SNP interactions
(see Figure 5, and Figure 4E–4H). For simplicity, the allelic
frequency of both SNPs and their main effect on the quantitative
trait was set to be equal. To account for all possible pairwise SNP-
SNP interactions between 340,000 SNPs, the ‘‘conventional’’ P-
value threshold was set at 4.3610
213. Figure 5 illustrates the
power that either SNP will have a Levene’s test P-value lower than
the pre-specified cut-off, and compares it to the power to detect
the interaction by exhaustive linear regression testing. Once again,
(A,B), the minor allele frequency was set at 0.2, the covariate-Y regression coefficient (i.e. b2) at 0.3, and b3 was chosen such that the proportion of
variance explained by the interaction was 0.1% and 0.15%, respectively. These conditions match those of Figure 3B. In (C,D), the minor allele
frequency was set at 0.1, the covariate-Y regression coefficient (i.e. b2) at 0.7, and b3 was chosen such that the proportion of variance explained by the
interaction was 0.1% and 0.15%, respectively. These conditions match those of Figure 3D. SNP–SNP interactions were simulated in (E–H). As in
Figure 5, the allelic frequency of both SNPs was set to be equal, as well as the SNP-Y regression coefficient (i.e. b1 and b2). For SNP–SNP interactions,
all prioritized SNPs were tested against all SNPs (not limited to prioritized ones). Red lines represent the power to detect the interaction with linear
regression when correcting for all pairwise interactions between 340,000 SNPs (P,4.3610
213). In (E,F), the minor allele frequency was set at 0.1, the
SNP-Y regression coefficient at 0.4, and b3 was chosen such that the proportion of variance explained by the interaction was 0.2% and 0.25%,
respectively. These conditions match those of Figure 5A. In (G,H), the minor allele frequency was set at 0.2, the SNP-Y regression coefficient at 0.1, and
b3 was chosen such that the proportion of variance explained by the interaction was 0.2% and 0.25%, respectively. These conditions match those of
Figure 5B.
doi:10.1371/journal.pgen.1000981.g004
Figure 5. Power to detect a SNP–SNP interaction effect as function of the proportion of variance explained by the interaction. Each
condition was simulated 1,000 times with 15,000 individuals. For simplicity, both SNPs were assigned the same allelic frequency (MAF) as well as the
same SNP-Y b coefficient (i.e. b1=b2). Upper panel: Power to identify either SNP1 or SNP2 as an ‘‘interacting’’ SNP using Levene’s test with a P-value
threshold of 0.05 (black), 0.01 (red) and 1.5610
27 (green; to account for 340,000 tests using Bonferroni correction). Also shown is the power to detect
the interaction itself with a linear regression interaction P-value cut-off of 4.3610
213 (blue; chosen to account for all possible pairwise interactions
between 340,000 SNPs). Lower panel: The variance per genotype is illustrated as a function of the fraction of the total variance of the quantitative
trait explained by the interaction. The homozygous major allele genotype is drawn in black, the heterozygous genotype in red and the homozygous
minor allele genotype in green.
doi:10.1371/journal.pgen.1000981.g005
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Levene’s test was higher than the power to identify the SNP-SNP
interaction using exhaustive linear regression testing when the
interaction effect was weak, providing the basis for prioritization of
SNPs with Levene’s test. Results of variance prioritization are
shown in Figure 4E and 4F and Figure 4G and 4H, matching the
conditions of Figure 5A and 5B, respectively, and fixing B3 such
that 0.2% or 0.25% of the variance was explained by the
interaction. In these simulations, all SNPs with Levene’s test P-
value lower than the specified threshold were prioritized and tested
for interaction against all other SNPs, prioritized or not (with
appropriate correction for multiple hypothesis testing). This
approach was shown (by simulations) to be more powerful than
testing for pairwise interactions between Levene’s test prioritized
SNPs only, which was underpowered as compared to an
exhaustive search (data not shown). As illustrated in Figure 4E,
the power of variance prioritization was superior to exhaustive
search under specific conditions. For example, when a Levene’s P-
value lower than 0.1 was chosen as the prioritization threshold, the
power of variance prioritization was 9.05% as compared to 7.30%
when testing all possible pairwise interactions between 340,000
SNPs. However, variance prioritization was associated with
decreased power in certain conditions, as illustrated in Figure 4G
and 4H.
To empirically test whether some SNPs exhibit inequality of
variance between genotypes and whether these effects might be
due to interactions, we applied Levene’s test of equality of variance
to ongoing genome scans of two inflammatory markers, C-reactive
protein (CRP) and soluble ICAM-1 (sICAM-1). Only SNPs with
genome-wide significant Levene’s P-value were selected for
subsequent study in order to ensure they represent true positives.
From the analysis of our sample of 21,799 women, 23 SNPs had a
Levene’s test P-value lower than 1.5610
27 for CRP (all clustering
near the LEPR gene on chromosome 1). Because the LEPR SNPs
are in linkage disequilibrium, only rs12753193 will be further
considered since it had the most significant Levene’s test P-value.
Two SNPs, the PNPLA3 SNP rs738409 and the ICAM1 SNP
rs1799969, had genome-wide significant Levene’s test P-value for
sICAM-1 (see Figure 6 and Table S1). To further characterize
these SNPs, we then tested all pairwise interactions with the
339,595 remaining SNPs as well as environmental covariates,
using linear regression. No SNP-SNP interaction was observed
after correction for multiple hypothesis testing. Three SNP-
environment interactions were significant after correction for
multiple hypothesis testing (P,0.05/(3 SNPs66 traits); see
Table 1). The LEPR SNP rs12753193 interacted with BMI in
the prediction of CRP levels (P=7.2610
210), the ICAM1 SNP
rs1799969 interacted with smoking status in the prediction of
sICAM1 levels (P=4.8610
29) and the PNPLA3 SNP rs738409
interacted with BMI in the prediction of sICAM1 levels
(P=1.6610
27).
We sought to determine the contribution of the three
interactions to Levene’s test of inequality of variance. While
Levene’s test P-value was 1.6610
229 for the LEPR SNP
rs12753193 in the CRP analysis, the P-value was 9.1610
221 after
adjustment for the interaction for BMI. Similarly, Levene’s test P-
values were 2.1610
29 for the ICAM1 SNP rs1799969 and
1.9610
210 for the PNPLA3 SNP rs738409 in the sICAM-1
analysis but were slightly less significant after adjustment for the
intraction with BMI and smoking status, respectively, at 3.3610
29
and 1.6610
27. Overall, these interactions explained 0.18% of
CRP total variance, and 0.16% and 0.13% of sICAM-1 total
variance for the ICAM1 and PNPLA3 interactions, respectively.
Neither the LEPR SNP rs12753193 nor the PNPLA3 SNP
rs738409 was associated with BMI (P.0.05). The ICAM1 SNP
rs1799969 was not associated with smoking status (P.0.05). These
data collectively suggest that individual interactions are likely to
have modest effects, and that additional covariates and/or SNPs
might interact with the validated SNP.
Discussion
Genetic effects on the variance of quantitative traits have been
largely ignored so far in the genetic analysis. As shown in this
report, differences in the variance per genotype can reflect
interaction effects and these differences can be leveraged to
Figure 6. Quantile–quantile plots. Illustrated in (A) is the quantile-quantile plot of Levene’s test of inequality of variance P-values applied to log-
CRP for 339,596 SNPs in our set of 21,799 individuals. Illustrated in (B) is the quantile-quantile plot of Levene’s test P-values applied to sICAM-1 in the
same set of individuals.
doi:10.1371/journal.pgen.1000981.g006
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variance prioritization, presents the distinct advantage that it does
not rely on the marginal effect of SNPs on the means to prioritize
them. Importantly, it can be used in combination with
prioritization based on marginal effects (on the means) if it is
assumed all interacting SNPs have a main effect on the trait of
interest. In such case, combining variance prioritization to
prioritization based on a pre-defined marginal effect P-value
provides the greatest power as compared to each procedure
individually, if the assumption that interacting SNPs have main
effects is true (data not shown). Another interesting property of this
method is the fact that the interacting covariate need not be
measured or even known to arouse suspicion of an interaction
effect, perhaps leading to novel biological insight.
The goal of any genetic prioritization method is to form a subset
of genetic variants enriched for the effect of interest. Variance
prioritization results in substantial reduction in multiple hypothesis
correction and hence increases power by using the information
embedded within the variance per genotype, which we showed is
independent from subsequent interaction testing. In this case, a
frequentist approach was adopted since prior knowledge on the
nature of the contribution of genetic interactions to complex traits
is currently scarce. Our simulations have shown that the optimal
Levene’s test P-value threshold for variance prioritization will
depend upon the allelic frequency, sample size, association of the
covariate with the quantitative trait, and expected strength of the
interaction. In most cases, all of these parameters can be directly
observed with the exception of the interaction strength. The
optimal threshold can therefore be empirically selected through
simulations when the potentially interacting covariate (or SNP) is
characterized and the expected interaction effect size defined.
Inequality of variance between genotypes could be the result of
factors other than interactions, such as increased variability.
Furthermore, the heteroscedacity of variances also depends on an
assumption of homogeneity of variances within genotype, which
could be violated if variances tend to be proportional to means.
This might reflect an inappropriate choice of scale for the
phenotype and a variance-stabilizing transform like the log or
square root might then be indicated. Linkage disequilibrium with
variants of large effect sizes could also theoretically lead to
inequality of variance between genotypes. Conversely, non-
additive interactions or SNPs with a multiplicity of interactions
may not result in deviation of Levene’s test. Failure to prioritize
‘‘interacting’’ SNPs or prioritization of ‘‘non-interacting’’ SNPs
can theoretically lead to decreased statistical power but should not
lead to inflated type I error since the first step is a screening test
followed by confirmatory analysis. While care was taken to
simulate models with plausible effect sizes (i.e. explaining less than
1% of total variance), the scenarios described in this report
undoubtedly represent simplified situations. Nevertheless, these
simulations suggest that variance prioritization has increased
power to detect genetic interactions of very modest strength in
situations where conventional methods perform poorly.
Genetic effects on variance in an empirical dataset led to the
identification of three novel interactions. Given the strength of the
observed interactions, they would have also been identified with
traditional methods. The significance of these results resides in (1)
the existence of SNPs with inequality of variance between
genotypes at genome-wide significance and (2) the presence of
biologically plausible interactions between these SNPs and
environmental factors. The first interaction involved the leptin
receptor SNP rs12753193 in the prediction of CRP. Leptin is a
protein synthesized and secreted by the adipose tissue whose main
function is to regulate appetite trough interaction with the leptin
receptor in the hypothalamus [16]. As such, leptin levels are
directly proportional to BMI and patients deficient in either leptin
or leptin receptor are characterized by marked obesity [17].
Interestingly, LEPR is also expressed by the liver, the source of
circulating plasma CRP, and physiological concentrations of leptin
stimulate expression of CRP in primary hepatocytes [18]. This
might explain why only a small fraction of the inequality of
variance between the LEPR SNP rs12753193 genotypes was due
to the interaction with BMI: the statistical interaction may only
capture a small fraction of the underlying biological interaction
between leptin levels and its receptor.
The LEPR SNP rs12753193 is known to be associated with
CRP concentration at a genome-wide level [19]. The minor allele
of rs12753193 (i.e. ‘‘G’’) is associated with lower levels of CRP and
was shown in this report to be associated with a greater effect of
BMI on CRP concentrations. This confirms the soundness of using
marginal effects of SNPs to select a subset for interaction testing.
No other SNP with genome-wide significance for CRP showed
evidence of inequality of variance between genotypes (excluding
SNPs in linkage disequilibrium with rs12753193).
The second interaction observed involved the ICAM1 SNP
rs1799969 in the prediction of sICAM-1 levels. The latter SNP is a
coding non-synonymous SNP (G241R) known to be associated
with sICAM-1 levels [20–22] and was shown in this report to
interact with smoking status. Smoking is a very strong determinant
of sICAM-1 levels (explaining up to 13% of sICAM-1 total
variance) and was associated with a stronger effect of rs1799969 in
WGHS. Interestingly, an interaction between another ICAM1
non-synonymous SNP (rs5498, r
2=0.17 with rs1799969) and
smoking was recently described with regards to susceptibility to
coronary artery disease [23].
The third interaction identified involved the PNPLA3 SNP
rs738409 in the prediction of sICAM-1. PNPLA3 encodes a
protein of unknown function that belongs to the patatin-like
Table 1. Gene–environment interactions.
Trait
Interacting
SNP MAF Chr
Position
(Kb)
Nearest
Gene Type Covariable
Variance of
A1A1* (N)
Variance of
A1A2* (N)
Variance of
A2A2* (N)
Levene’s
P-value
Interaction
P-value
CRP
rs12753193 0.38 1 65942.3 LEPR - BMI 1.27 (8491) 1.47 (10126) 1.68 (3167) 1.6E-29 7.2E-10
sICAM-1
rs1799969 0.11 19 10255.8 ICAM1 Missense Smoking 6621 (17063) 5316 (4421) 4104 (300) 2.1E-09 4.8E-09
rs738409 0.22 22 42656.1 PNPLA3 Missense BMI 6087 (13098) 6743 (6965) 9205 (1110) 1.9E-10 1.6E-07
*A1A1: Homozygous Major Allele; A1A2: Heterozygous; A2A2: Homozygous Minor Allele.
doi:10.1371/journal.pgen.1000981.t001
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PNPLA3 SNP rs738409 (Ile148Met) has recently been associated
with increased hepatic fat levels, hepatic inflammation and plasma
levels of liver enzymes (traits often linked to insulin resistance and
obesity) [24]. Interestingly, that same variant has been associated
with insulin secretion in response to oral glucose tolerance test
[25]. Levels of the inflammatory marker sICAM-1 are known to
be correlated with insulin resistance and obesity [26]. Consistent
with this literature, the methionine allele was associated with
sICAM-1 itself (P=2.2610
27; Beta=4.9 ng/mL per minor allele)
while being associated with a greater effect of BMI on sICAM-1
levels.
In this report, we demonstrated that the presence of gene-gene
or gene-environment interactions can result in changes in variance
of a quantitative trait per genotype and that these changes can be
exploited to prioritize SNPs for interaction testing. We used this
property of quantitative trait interactions on a real dataset and
discovered three new, biologically relevant, interactions. Variance
prioritization presents two advantages over other methods. First, it
does not depend on the marginal effect of SNPs on the means.
Second, it can identify SNPs likely to be involved in an interaction
even when the interacting genetic or environmental covariate(s) is
not measured. For instance, had BMI or smoking status not been
assessed in the WGHS, the LEPR SNP rs12753193, the ICAM1
SNP rs1799969 and the PNPLA3 SNP rs738409 would still have
been selected as candidates for interaction effects, perhaps leading
to novel biological hypotheses.
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